TY  - GEN
AU  - Blandini,Fabio
AU  - Armentero,Marie-Therese
TI  - New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
SN  - 1744-7658
PY  - 2012///0501
KW  - Animals
KW  - Antiparkinson Agents
KW  - adverse effects
KW  - Dyskinesias
KW  - drug therapy
KW  - Excitatory Amino Acid Antagonists
KW  - therapeutic use
KW  - Humans
KW  - Levodopa
KW  - Parkinson Disease
KW  - Purinergic P1 Receptor Antagonists
KW  - Receptors, Glutamate
KW  - metabolism
KW  - Receptors, Purinergic P1
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1517/13543784.2012.651457
ER  -